A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma

Yilu Feng(Central South University), Yongheng Chen(Central South University)
Cell Death and Disease
February 3, 2020
10.1038/s41419-020-2278-6
Cited by 111

Related Papers

Recent advances in therapeutic strategies for triple-negative breast cancer
|Journal of Hematology & Oncology|2022|892
Targeting p53 pathways: mechanisms, structures and advances in therapy
|Signal Transduction and Targeted Therapy|2023|857
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
|Nature Communications|2021|114
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
|Nature Communications|2023|95
Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma
|Pharmaceuticals|2022|84